在接受冠状动脉和结构性心脏干预的患者中,高出血风险
Mattia Galli1, Domenico D'Amario2
1Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1, Cotignola 48033, Ravenna, Italy.
接受皮肤冠状动脉和结构性心脏干预的患者通常需要抗血栓治疗. 本摘要详细介绍了这些患者的高出血风险,平衡了血栓事件预防与出血并发症.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
背景情况:
- 穿皮冠状动脉和结构性心脏干预越来越多地受到传统手术的青.
- 这些手术减少了并发症和更快的恢复.
- 然而,他们需要抗血栓治疗来预防血栓事件.
研究的目的:
- 为提供高出血风险的综合分类.
- 描述高出血风险的临床相关性.
- 为了指导心脏干预的患者的管理.
主要方法:
- 关于抗血栓治疗和出血风险的文献综述.
- 对出血风险的分类系统的分析.
- 结合出血并发症的临床影响.
主要成果:
- 抗血栓治疗是必不可少的,但会增加出血风险.
- 出血风险与抗血栓剂的强度和持续时间成正比.
- 出血的临床影响可能会抵消预防血栓事件的好处.
结论:
- 高出血风险是干预心脏病学的关键考虑因素.
- 准确的分类和了解出血风险至关重要.
- 管理策略必须平衡抗血栓疗效与避免出血.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
相关概念视频
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Esophageal Varices-I: Introduction
Measurement of Blood Pressure
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
